Ellina Allais

Ellina Allais (Kovalenko) is a seasoned professional in regulatory affairs with extensive experience in the pharmaceutical industry. Currently serving as Senior Director Regulatory Affairs and Global Regulatory Team Lead at Cellectis since February 2019, Ellina oversees the regulatory development of CAR T-cell therapies and gene-edited products. Previous roles include Senior Director Global Regulatory Affairs, Team Lead, and Director Global Regulatory Affairs at Cellectis, as well as Regulatory Affairs Project Manager at Servier, focusing on drug development and registration across multiple countries. Ellina's academic background includes a Master's degree in International Drug Development and Registration from Paris-Sud University and a State Diploma of Pharmacist from Bogomolets National Medical University, where Ellina also served as a doctoral researcher and professor.